Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 5 of 25

ACTIVE NOT RECRUITING Phase 1

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT05744739

ACTIVE NOT RECRUITING NA

Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)

NCT05375162

ACTIVE NOT RECRUITING NA

TECH App Marijuana Use Intervention for Court-Involved Adolescents

NCT05979272

ACTIVE NOT RECRUITING NA

Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial

NCT05656560

ACTIVE NOT RECRUITING NA

Sleep and Health Outcomes in Women With Heavy Menses

NCT05722444

ACTIVE NOT RECRUITING

Artificial Intelligence Patient App for RDEB SCCs

NCT05843994

ACTIVE NOT RECRUITING Phase 2

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

NCT05545150

ACTIVE NOT RECRUITING

Liver Cirrhosis Network Cohort Study

NCT05740358

ACTIVE NOT RECRUITING Phase 2

Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer

NCT04931017

ACTIVE NOT RECRUITING NA

Home Semen Testing in Men Beginning Attempts to Conceive

NCT05503862

ACTIVE NOT RECRUITING NA

ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings

NCT04852601

ACTIVE NOT RECRUITING Phase 4

Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis

NCT05430230

ACTIVE NOT RECRUITING Phase 1

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

NCT05236036

ACTIVE NOT RECRUITING NA

Potassium Citrate and Crystal Light Lemonade

NCT05389995

ACTIVE NOT RECRUITING Phase 2

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

NCT05453799

ACTIVE NOT RECRUITING Phase 2

Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma

NCT05202782

ACTIVE NOT RECRUITING NA

Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care

NCT04869917

ACTIVE NOT RECRUITING Phase 4

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

NCT05325073

ACTIVE NOT RECRUITING

COVID-19 & Psychiatry: A Retrospective Chart Review

NCT05244096

ACTIVE NOT RECRUITING Phase 2

Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer

NCT04576104

ACTIVE NOT RECRUITING Phase 2

A Hybrid Type II Trial of the Optimizing Resilience and Coping With HIV Through Internet Delivery in Ryan White Clinics in Chicago

NCT05123144

ACTIVE NOT RECRUITING

Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome

NCT05185180

ACTIVE NOT RECRUITING Phase 2

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

NCT04767984

ACTIVE NOT RECRUITING NA

APOL1 Genetic Testing Program for Living Donors

NCT04910867

ACTIVE NOT RECRUITING NA

Progressive Abduction Loading Therapy

NCT04118998

ACTIVE NOT RECRUITING NA

The OPTIMIZE Study: Optimizing Patient Navigation for Perinatal Care

NCT04261894

ACTIVE NOT RECRUITING NA

Stepping to Understand Lower Limb Impairments in Bilateral Cerebral Palsy

NCT04957277

ACTIVE NOT RECRUITING Phase 2

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04550481

ACTIVE NOT RECRUITING

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

NCT04860336

ACTIVE NOT RECRUITING NA

Using Information Technology to Improve Outcomes for Children Living With Cancer

NCT04789720

ACTIVE NOT RECRUITING NA

Elements Vital to Treat Obesity Study

NCT04708769

ACTIVE NOT RECRUITING Phase 2

Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

NCT05463367

ACTIVE NOT RECRUITING NA

Essential Oils for Electrocautery

NCT04260867

ACTIVE NOT RECRUITING Phase 1

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

NCT04250051

ACTIVE NOT RECRUITING NA

Patient Navigation 2.0

NCT04234646

ACTIVE NOT RECRUITING Phase 1

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

NCT04528680

ACTIVE NOT RECRUITING Phase 2

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

NCT04009044

ACTIVE NOT RECRUITING NA

Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults

NCT03960476

ACTIVE NOT RECRUITING Phase 2

Platelet-rich Plasma for Eyebrows

NCT04018859

ACTIVE NOT RECRUITING Phase 1

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NCT04047706

ACTIVE NOT RECRUITING NA

Lupus Intervention for Fatigue Trial

NCT02653287

ACTIVE NOT RECRUITING Early Phase 1

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

NCT03831334

ACTIVE NOT RECRUITING Phase 1

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

NCT03513484

ACTIVE NOT RECRUITING Phase 2

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

NCT03667404

ACTIVE NOT RECRUITING

Adaptations of the Brain in Chronic Pain With Opioid Exposure I

NCT05203770

ACTIVE NOT RECRUITING

Evaluation of a Collaborative Behavioral Health Program Implementation in Primary Care

NCT04321876

ACTIVE NOT RECRUITING Early Phase 1

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

NCT03392181

ACTIVE NOT RECRUITING NA

Biology, Identity & Opportunity Study

NCT03412162

ACTIVE NOT RECRUITING Phase 3

Improve PAD PERformance With METformin

NCT03054519

ACTIVE NOT RECRUITING Phase 4

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

NCT03016741

← Previous Page 5 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.